Table 1.
Clinicopathological characteristics of 142 patients
| Characteristics | Total (n = 142) | Control (n = 71) | DC-CIK (n = 71) | p value |
|---|---|---|---|---|
| Sex, male/female | 79/63 | 40/31 | 39/32 | 0.44 |
| Age (years), mean ± SD | 55.4 ± 14.4 | 55.6 ± 14.3 | 55.3 ± 14.6 | 0.90 |
| KPS, mean ± SD | 70.4 ± 6.3 | 70.1 ± 5.7 | 70.6 ± 6.8 | 0.79 |
| Adenocarcinoma | ||||
| Well differentiated | 3 | 2 | 1 | 0.75 |
| Moderately differentiated | 104 | 54 | 50 | |
| Poorly differentiated | 22 | 9 | 13 | |
| Unknown | 13 | 6 | 7 | |
| TNM stage (III/IV) | 98/54 | 41/30 | 47/24 | 0.27 |
| FOLFIRI chemotherapy cycles | ||||
| ≤ 3 | 32 | 19 | 15 | 0.59 |
| 4–6 | 33 | 18 | 16 | |
| > 6 | 44 | 21 | 24 | |
| Radiotherapy (yes/no) | 49/93 | 22/49 | 27/44 | 0.31 |